- Senior Investigator, OFFICE OF THE DIRECTOR
Dr. Montserrat García-Closas investigates the causes of cancer with the aim of improving risk assessment tools that can aid the development of targeted screening and risk reduction strategies for personalized prevention. She carries out a multidisciplinary research program on the molecular epidemiology of breast and bladder cancers, and has made important contributions to the understanding of genetic susceptibility and etiologic heterogeneity of these malignancies.
As Deputy Director for the NCI Division of Cancer Epidemiology and Genetics (DCEG) she focuses not only on her own research interests, but also on the management of the broad scientific program of the Division.
Dr. García-Closas received her M.D. from the University of Barcelona, Spain, a Master of Public Health in quantitative methods, and a Doctorate of Public Health in epidemiology from the Harvard School of Public Health. She joined DCEG in 1996 as a postdoctoral fellow, became a tenure-track investigator in 1999 and a tenured senior investigator in 2007. From 2008-2010, she was a visiting scientist at the Department of Oncology and Strangeways Laboratory, Cambridge University, U.K. In 2010, she became a Professor of Epidemiology at the Division of Genetic and Epidemiology of the Institute of Cancer Research (ICR), University of London, U.K.
She is the recipient of several awards including two NIH Merit Awards, an NCI Intramural Research Award, and an NCI Mentor of Merit Award. She has also served in numerous expert committees including the American Association for Cancer Research (AACR) Molecular Epidemiology Working Group (MEG), the U.K. MEG and the Advisory Committee on NHS Breast Cancer Screening, England. She is a founder member of several large consortia, served as the Chair of the Coordinating Committee for the International Consortium of Case-Control Studies of Bladder Cancer from 2005-2011, and co-Chairs the Pathology and Survival Working Group of the Breast Cancer Association Consortium (BCAC), a major breast cancer consortium.
- (2020). Reproductive factors and risk of breast cancer by tumor subtypes among Ghanaian women: A population-based case-control study. INTERNATIONAL JOURNAL OF CANCER. 147(6), 1535-1547.
- (2020). Combined Utility of 25 Disease and Risk Factor Polygenic Risk Scores for Stratifying Risk of All-Cause Mortality. AMERICAN JOURNAL OF HUMAN GENETICS. 107(3), 418-431.
- (2020). Personalized early detection and prevention of breast cancer: ENVISION consensus statement (vol 77, pg 635, 2020). Nature Reviews Clinical Oncology. 17(11), 716-716.
- (2020). Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nature Reviews Clinical Oncology. 17(11), 687-705.